The content on this site is intended for healthcare professionals only
Prof Martinelli talks to ecancertv at EHA 2014 about the use of novel targets in acute myeloid leukaemia.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isa-KRd quad regimen in NDMM: MIDAS and CONCEPT studies
ESMO 2024: Optimising the personalisation of prostate cancer treatment
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
